Dear BingX Users,
The second batch of compensation for abnormal displays of Perpetual Futures Order Book and Open Orders on 2023-07-13 has been distributed. You can now check it in your Fund Account.
For any questions, please feel free to contact BingX online support or the customer service email at support@bingx.com. You can also click on the Compensation Feedback Form to submit relevant information for further review before 2023-07-30 18:00 (UTC+8).
For compensation details, please refer to the announcement: Compensation Plan for the Abnormal Display of Perpetual Futures Order Book and Open Orders for Some Users on 2023-07-13
Thank you for your understanding and support!
BingX Operation Team
2023-07-15
BingX Official Channels
BingX App: https://bingx.com/download/
BingX Web: https://bingx.com
Telegram: https://t.me/BingXOfficial
Twitter: https://twitter.com/BingXOfficial
YouTube: https://www.youtube.com/c/bingx
Risk Disclaimer
Cryptocurrency prices are subject to high market risk and price volatility. You should only invest in products that you are familiar with and where you understand the associated risks. You should carefully consider your investment experience, financial situation, investment objectives and risk tolerance and consult an independent financial adviser prior to making any investment. This material is for reference only and should not be construed as financial advice. Past performance is not a reliable indicator of future performance. The value of your investment can go down as well as up, and you may not get back the amount you invested. You are solely responsible for your investment decisions. BingX is not responsible for any losses you may incur.
BingX attaches great importance to compliance and strictly abides by local regulations. Please obey local laws and regulations in your country or region. BingX reserves the right in its sole discretion to amend, change, or cancel this announcement at any time and for any reason without prior notice.
For more information, please refer to our Terms of Use and Risk Warning.